Generated Q3 2025 Net Revenue of $38.2 million and year-to-date revenue of $114.3 million; reaffirmed 2025 Net Revenue Guidance of $153 million - $163 million and adjusted EBITDA of $9.0 - $13.0 ...
19hon MSN
What Does Fentanyl Have to Do With Alleged Drug Boats 2,600 miles away? Absolutely Nothing.
President Donald Trump has ordered the killing of 64 people through "lethal kinetic strikes," with three more deaths reported ...
Baxter International stock hits 20-year low, but undervaluation and new CEO strategy offer turnaround potential.
Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme" or the "Company") today reported its financial and operating results for the third quarter ended September 30, 2025 and provided an update on its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback